In the News
A collection of the most recent news, press mentions, and media assets.
Recent Mentions
Experiencing Shame and Guilt on Mushrooms Might Actually Be Good for You
The Drop In
March 3, 2025
A new study finds that experiencing shame and guilt during psilocybin trips is common— and for those who can process these emotions, it may lead to greater positive outcomes.
“Bad trips” and guilt: Why difficult feelings during psychedelic use might actually be a good thing
PsyPost
February 21, 2025
A recent study in the Journal of Psychoactive Drugs has shed light on a less discussed aspect of psychedelic experiences: the feelings of shame and guilt that can arise during these journeys.
What is Naturalistic Research?
The Drug Science Podcast
January 15, 2025
In this episode, Dr. Matthew X. Lowe and Professor David Nutt discuss the vital role of observational and longitudinal research when it comes to the medicalisation of cannabis and psychedelics — and the importance for safetyof bringing real-world data into our collective knowledge base.
Older Features
Top 25 Emerging Leaders in Psychedelic Research and Modern Theory
Webdelics - December 16, 2024
Executive Director Matthew X. Lowe was featured on Webdelic's list of the trailblazers conducting research and promoting understanding of psychedelics as tools for mental health treatment and personal development.
View
Psilocybin Doesn't Alter Belief or Disbelief in God, Study Suggests
High Times - May 16, 2024
The study, “Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study,” published May 7 in the Journal of Psychoactive Drugs.
View
Psilocybin Study: No Change in View of God. Some Change in View of Bugs.
Filter Magazine - May 14, 2024
"These findings suggest that concerns that psychedelics could change metaphysical beliefs or result in ‘conversions’ across religious affiliations may be overestimated,” the authors wrote, adding that “concerns related to changes in non-naturalistic beliefs or religious affiliation may be exaggerated.”
View
Psychedelic Mushrooms Won’t Make You Believe In God, But They Might Make You Think Robots Are Conscious, Study Finds
Marijuana Moment - May 14, 2024
The study, published this month in the Journal of Psychoactive Drugs, surveyed hundreds of people who planned to use psilocybin in a non-laboratory setting, asking them about their beliefs both before and at two separate times after their experiences. While participants reported small differences in certain perceptions of consciousness after the psychedelic experiences, their religious and metaphysical beliefs didn’t significantly change.
View
Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences
Bezinga - April 29, 2024
Welcome to a new episode of the Benzinga Psychedelics Podcast where we’re joined by Dr. Matthew X. Lowe, executive director and CSO to Unlimited Sciences, a Colorado-based nonprofit organization conducting and supporting research with psychedelics. Unlimited Sciences recently launched a toll-free "Psychedelic Info Line" to provide pre-psychedelic education and guidance.
View
How lessons from the cannabis industry will impact Colorado’s budding psychedelic scene.
Denver Business Journal - April 19, 2024
As retail cannabis enters its second decade and the psychedelic market takes shape in Colorado, industry watchers discuss the future of each market.
View
3 Non-Profits Explore Functional Mushrooms for Epilepsy: Hope for Advanced Healing in Nature's Bounty
Cannabis Tech - March 26, 2024
A testimony to the enduring power of maternal love, the pursuit of healing, the unshakable belief in the potential of a brighter future, and the discovery of the potential of functional mushrooms for epilepsy. Compassion, scientific inquiry, and maternal determination coincide in a groundbreaking venture with a shared purpose and collaboration.
View
5 Things We Learned From the World's First Psychedelic Hotline
5280 - March 25, 2024
In February, Lowe’s team at Unlimited Sciences was able to launch a similar service for psychedelics with support from the Wana Brands Foundation. Now, anyone interested in hallucinogenic mushrooms, ayahuasca, or other psychedelic substances can call 1-888-210-3553 and be connected directly with a trained navigator.
View
Meet Muscimol, the Compound Behind the Unique Amanita Mushroom Trip
Double Blind - March 20, 2024
As retail cannabis enters its second decade and the psychedelic market takes shape in Colorado, industry watchers discuss the future of each market.
View
Safely Explore Psilocybin Mushrooms with Unlimited Sciences
Out Front Magazine - March 8, 2024
Not everyone has had a psychedelic experience in their lifetime, and that’s more than okay, but, with or without the experience, being educated on psilocybin can be groundbreaking and quite interesting to say the least. That’s why research nonprofit Unlimited Sciences is dedicated to providing the public with intensive knowledge on psilocybin mushrooms. Their purpose is to provide harm reduction resources for anyone with the desire to partake in the exploration of psychedelics.
View
Psychedelics Improve Sexual Gratification for Months After Use, New Research Says
Double Blind - February 19, 2024
And in September, researchers at Johns Hopkins University, Ohio State University and Unlimited Sciences published findings showing an association between psilocybin use and “persisting reductions” in depression, anxiety and alcohol misuse—as well as increases in emotional regulation, spiritual wellbeing and extraversion.
View
Tripping? Nonprofit Launches New Psychedelic Info Hotline
Business Wire - February 12, 2024
Legal or not, people are experimenting with psychedelics, and they might as well be informed about their decisions in a logical manner, making situations safer. Colorado-based Unlimited Sciences, a psychedelic research nonprofit, unveiled the Psychedelic Info Line, a hotline that provides callers with data-driven education and informed resources for individuals considering exploring psychedelics.
View